Given that predicting the prognosis of CRC patients using a single biomarker or clinical characteristic is often difficult, we developed a comprehensive prognostic nomogram model that integrates CLDN18 and FTCD with clinical factors like age and gender. Here, CLDN18 is linked to colorectal carcinoma.